Publications by authors named "Jason Appelbaum"
Article Synopsis
- Ventricular tachycardia (VT) in cardiac sarcoidosis (CS) is linked to high mortality rates, and catheter ablation could offer better outcomes compared to traditional medical management.
- A study analyzed data from 158 patients with CS and VT at 16 medical centers over 16 years, focusing on the effectiveness of catheter ablation and accompanying medical treatments.
- Results showed that 54% of patients had complete success with ablation, with a significant reduction in VT storms and defibrillator shocks, although 46% experienced VT recurrence over a follow-up period of about 2.5 years.
Arrhythmias in Cardiac Sarcoidosis Bench to Bedside: A Case-Based Review.
Circ Arrhythm Electrophysiol
February 2021
Cardiac sarcoidosis is a component of an often multiorgan granulomatous disease of still uncertain cause. It is being recognized with increasing frequency, mainly as the result of heightened awareness and new diagnostic tests, specifically cardiac magnetic resonance imaging and F-fluorodeoxyglucose positron emission tomography scans. The purpose of this case-based review is to highlight the potentially life-saving importance of making the early diagnosis of cardiac sarcoidosis using these new tools and to provide a framework for the optimal care of patients with this disease.
View Article and Find Full Text PDFBackground: An electrical storm (ES) is a life-threatening condition that affects up to 20% of patients with implantable cardioverter defibrillators. In this small retrospective study, we report our results with left video-assisted thoracoscopic sympathectomy/ganglionectomy (VATSG) to treat refractory ES in low-ejection fraction patients who were not candidates for catheter ablation.
Methods: We identified 12 patients who presented with ES and underwent a total of 14 video-assisted thoracoscopic sympathectomy/ganglionectomy, including 3 patients on venoarterial extracorporeal membrane oxygenation.